These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2565896)

  • 1. Nobel lecture in physiology or medicine--1988. Drugs from emasculated hormones: the principle of syntopic antagonism.
    Black J
    In Vitro Cell Dev Biol; 1989 Apr; 25(4):311-20. PubMed ID: 2565896
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs from emasculated hormones: the principle of syntopic antagonism.
    Black J
    Biosci Rep; 2004; 24(4-5):302-22. PubMed ID: 16134017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sir James Black (1924-2010), β-blockers and liver disease.
    Erlinger S
    Gastroenterol Clin Biol; 2010 Oct; 34(10):513-5. PubMed ID: 20943336
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs from emasculated hormones: the principle of syntopic antagonism.
    Black J
    Biosci Rep; 1989 Jun; 9(3):253-72. PubMed ID: 2570612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs from emasculated hormones: the principle of syntopic antagonism.
    Black J
    Science; 1989 Aug; 245(4917):486-93. PubMed ID: 2569237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nobel Prize in medicine: three share this year's Nobel Prize in medicine. Important principles in drug therapy].
    Sjöqvist F
    Lakartidningen; 1988 Oct; 85(43):3542-7. PubMed ID: 2462143
    [No Abstract]   [Full Text] [Related]  

  • 7. The major impacts of James Black's drug discoveries on medicine and pharmacology.
    Walker MJ
    Trends Pharmacol Sci; 2011 Apr; 32(4):183-8. PubMed ID: 21414672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From nerves and hormones to bacteria in the stomach; Nobel prize for achievements in gastrology during last century.
    Konturek SJ; Konturek PC; Brzozowski T; Konturek JW; Pawlik WW
    J Physiol Pharmacol; 2005 Dec; 56(4):507-30. PubMed ID: 16391411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sir James Black, Nobel laureate 1988].
    Meijler FL
    Ned Tijdschr Geneeskd; 1988 Dec; 132(53):2429-30. PubMed ID: 2905768
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive and adrenergic receptor blocking properties of the enantiomers of medroxalol.
    Cheng HC; Reavis OK; Grisar JM; Claxton GP; Weiner DL; Woodward JK
    Life Sci; 1980 Dec 22-29; 27(25-26):2529-34. PubMed ID: 6111723
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of some properties of pronethalol and propranolol. 1965.
    Black JW; Duncan WA; Shanks RG
    Br J Pharmacol; 1997 Feb; 120(4 Suppl):285-99; discussion 283-4. PubMed ID: 9142411
    [No Abstract]   [Full Text] [Related]  

  • 12. James Black & birth of beta blockers.
    Pai-Dhungat JV; Parikh F
    J Assoc Physicians India; 2009 Mar; 57():214. PubMed ID: 19588651
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT; Levy GP
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Nobel Prize for Medicine for the development of a therapeutic principle].
    Wink K
    Med Klin (Munich); 1989 Feb; 84(2):116-7. PubMed ID: 2565528
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of some properties of pronethalol and propranolol. 1965.
    Black JW; Duncan WA; Shanks RG
    Br J Pharmacol; 2010 Jul; 160 Suppl 1(Suppl 1):S28-42; discussion S26-7. PubMed ID: 20590649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects on the hemodynamics and myocardial contractility of 2 beta blockader agents: propranolol and proctolol].
    Sanguinetti M; Picchio FM; Maresta A; Branzi A; Baccarani G; Binetti G
    G Ital Cardiol; 1972; 2(5):710-9. PubMed ID: 4404053
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers].
    Gimeno JV; Martín G; Cosín J
    Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585
    [No Abstract]   [Full Text] [Related]  

  • 18. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacology of the novel H2 antagonist famotidine: in vitro studies.
    Bertaccini G; Coruzzi G; Poli E; Adami M
    Agents Actions; 1986 Nov; 19(3-4):180-7. PubMed ID: 2881455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacological evaluation of beta-receptor antagonists. II. The influence on the effect of isuprel by propranolol, oxprenolol, alprenolol in patients with essential circulatory hyperkinesis (ECH).
    Bekes M; Matos L; Rausch J; Török E
    Int J Clin Pharmacol; 1972 Aug; 6(3):209-13. PubMed ID: 4405377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.